Tim Pawlenty’s got a Union Leader op-ed that I guess is supposed to illustrate his resumé as a Presidential contender. But amidst all the fulminations, we get to the point that anytime people decide to stop playing stupid political stunts and start talking about real issues, the differences in our politics narrow considerably:
Last night, I argued that it was long past time for the debate over the public plan to get specific. In response, longtime commenter Wisewon -- who doesn't seem to be commenting much on the new site -- e-mailed his take. Wisewon has been in the industry a long time, and though I don't always agree with his perspective, I've long since learned to heed it. I wouldn't necessarily term what he's written an argument against the public plan.
A number of you have asked me what I think of Paul Ryan's health care plan. I think it's a serious plan--but it's serious in the way that serious government plans are, which is to say that it has virtually no hope of being enacted as written.Consider Matt Yglesias' relatively uncharitable, but accurate, summation:
Over the course of this week, I'll be asking some health-care experts what they'd like Santa to add to the bill during conference committee, and publishing their responses on the blog. In this post, Jacob Hacker, the Stanley B.
I've been saying that a public option with negotiated rates probably won't post much of a price advantage against private insurers. But according to the Congressional Budget Office (pdf), that's an overoptimistic take. The public option's premiums, they say, will actually be more expensive than private insurance:
Ezra Klein posted a super-long chart making this point yesterday, but it really can’t be said often enough. The overwhelming reason that health care is so expensive in the United States is that Americans pay high prices for health care services.
Health Net, Inc. (HNT) has seen its market value grow $1 billion this year to $3.4 billion as it benefits from its increased exposure to California, where the quick adoption of Obamacare and growth in the company’s Medicaid services is helping push its stock price higher. The stock has so far appreciated around 44% this year.